{"id":"NCT02558296","sponsor":"Theracos","briefTitle":"Bexagliflozin Efficacy and Safety Trial","officialTitle":"A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-10","primaryCompletion":"2018-08","completion":"2019-10-23","firstPosted":"2015-09-23","resultsPosted":"2021-07-07","lastUpdate":"2021-07-14"},"enrollment":1700,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Bexagliflozin","otherNames":["EGT0001442","EGT0001474"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Bexagliflozin tablets, 20 mg","type":"ACTIVE_COMPARATOR"},{"label":"Placebo tablets","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to investigate the effect of bexagliflozin in lowering hemoglobin A1c (HbA1c) levels in patients with type 2 diabetes mellitus (T2DM) and increased risk of cardiovascular adverse events.\n\nThe data from this study will be combined with the data from other bexagliflozin studies in a meta-analysis of CV safety outcomes.","primaryOutcome":{"measure":"Change in HbA1c From Baseline to Week 24","timeFrame":"24 weeks","effectByArm":[{"arm":"Bexagliflozin Tablets, 20 mg","deltaMin":-0.85,"sd":null},{"arm":"Placebo Tablets","deltaMin":-0.37,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":7},"locations":{"siteCount":157,"countries":["United States","Canada","Czechia","Denmark","Mexico","Netherlands","Poland","Russia","South Korea","Taiwan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":373,"n":1132},"commonTop":["Hypoglycaemia","Urinary tract infection","Upper respiratory tract infection","Nasopharyngitis","Hyperglycaemia"]}}